foxo4 dri senolytic peptide human trial 2024 2025 The in a conformation (D-amino acids in a retro-reversed sequence), henceforth named FOXO4-DRI, competes with FOXO4 for p53 binding in a dose-dependent manner and doing so with higher affinity general inflammation SS-31 Reconstitution: 5mg + Strength:2000mcg
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11